Lizhi He
- Molecular Biology top 10%
- Oncology top 10%
- Immunology top 10%
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Alexander G. MarnerosDamu TangAdrian P. RybakAnil KapoorKevin StruhlJean‐Claude CutzZhe JiAviv Regev
- Topics
- Cancer-related Molecular Pathways (7 papers)PI3K/AKT/mTOR signaling in cancer (6 papers)RNA Research and Splicing (5 papers)
- Cited by
- Cancer ResearchImmunologyOncology
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Investigation
- Partner nations
- CanadaUnited StatesChina
In The Last Decade
Lizhi He
35 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Molecular Biology 837
- Oncology 344
- Immunology 283
- Cancer Research 270
- Pulmonary and Respiratory Medicine 176
Countries citing papers authored by Lizhi He
This map shows the geographic impact of Lizhi He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lizhi He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lizhi He more than expected).
Fields of papers citing papers by Lizhi He
This network shows the impact of papers produced by Lizhi He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lizhi He. The network helps show where Lizhi He may publish in the future.
Co-authorship network of co-authors of Lizhi He
This figure shows the co-authorship network connecting the top 25 collaborators of Lizhi He. A scholar is included among the top collaborators of Lizhi He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lizhi He. Lizhi He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 74 | |
| 4 | Global characterization of macrophage polarization mechanisms and identification of M2-type polarization inhibitorsbreakdown → | 207 |
| 5 | 11 | |
| 6 | 28 | |
| 7 | 74 | |
| 8 | 17 | |
| 9 | 9 | |
| 10 | 105 | |
| 11 | 15 | |
| 12 | 23 | |
| 13 | 90 | |
| 14 | 53 | |
| 15 | 83 | |
| 16 | 20 | |
| 17 | 6 | |
| 18 | 25 | |
| 19 | 36 | |
| 20 | 32 |
About Lizhi He
Lizhi He is a scholar working on Cancer Research, Molecular Biology and Genetics, having authored 38 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and RNA Research and Splicing (5 papers). The work is most often cited by research in Cancer Research (270 citations), Immunology (283 citations) and Oncology (344 citations). Lizhi He has collaborated with scholars based in Canada, United States and China. Frequent co-authors include Alexander G. Marneros, Damu Tang, Adrian P. Rybak, Anil Kapoor, Kevin Struhl, Jean‐Claude Cutz, Zhe Ji, Aviv Regev, Fengxiang Wei and Alistair J. Ingram. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.